Lantheus Holdings appoints Mary Anne Heino as president and CEO
Ms. Heino brings to the Company more than 25 years of diverse pharmaceutical industry experience. Joining the Company in April 2013 as Chief Commercial Officer, she was promoted to Chief Operating Officer in March 2015.
Prior to joining the Company, Ms. Heino led Angelini Labopharm LLC and Labopharm USA in the roles of President and Senior Vice President of World Wide Sales and Marketing.
Before that, she served in numerous capacities atCentocor, Inc., a Johnson & Johnson Company, including Vice President Strategic Planning and Competitive Intelligence, Vice President Sales, Executive Director Customer Relationship Management and Senior Director Immunology Marketing.
Ms. Heino began her professional career with Janssen Pharmaceutica as a Sales Representative in June 1989 and worked her way up to the role of Field Sales Director in 1999. ■